26 Jun 2019 | 2:13 AM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
456.50
-4.09
(-0.89 %)
25 Jun 2019 | 03:32 PM
Change company
  • Open (Rs)
    470.05
  • Prev. close (Rs.)
    460.60
  • High (Rs.)
    470.05
  • Low (Rs.)
    451.75
  • 52W H (Rs.)
    706.90
  • 52W L (Rs.)
    451.75
  • Volume
    178951
  • MCap (Rs in Cr.)
    12,880.97
651.6
12.15
(1.90 %)
  • Open (Rs)
    640.05
  • High (Rs)
    652.50
  • Low (Rs)
    639.00
  • Prev. close(Rs)
    639.45
  • Contracts Tra.
    14,10,000
  • Turnover (Cr.)
    91
  • Open Interest
    9,00,000
  • Open Int. chg
    -9,40,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
32.78
Operating Margin (%)
16.07
Gross Profit Margin (%)
12.77
Net Profit Margin (%)
9.37
Total Debt/Equity
0.69
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

30 May 2019 - 13:00:00-The company reported standalone net profit of Rs 281...
06 Feb 2019 - 16:58:00-Drug firm Glenmark Pharmaceuticals Wednesday said its Swiss arm has entered into an exclusive licens...
08 Jan 2019 - 17:13:00-Glenmark Pharmaceuticals is targeting a consolidated revenue growth of up to 15 per cent over the ne...
20 Nov 2018 - 13:20:00-Glenmark Pharmaceuticals Tuesday said it has received approval from the US health regulator for Azel...

Announcements

22-Jun-2019
Glenmark Pharma - FDA Issues Complete Response Letter For RyaltrisT (Olopatadine Hydrochloride [665 Mcg] And Mometasone Furoa
24-Jun-2019
Glenmark Pharma partners with Novartis to promote three respiratory products in Brazil
24-Jun-2019
Glenmark Pharma gets USFDA Complete Response Letter for RyaltrisTM
24-Jun-2019
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
24-Jun-2019
Glenmark Pharma - Press Release

Religare Research

28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 71.42 0.48
10,00,000 115.06 60.45 0.48
10,00,000 115.06 216.46 0.48
10,00,000 115.06 229.04 0.48
10,00,000 115.06 76.76 0.48

Shareholding Pattern

       
Promotors46.54%
Mutual Funds/UTI4.18%
FI/Banks2.75%
Insurance2.75%
FII32.62%
Government0.00%
Others4.73%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
8,560.00(0.27)
3280
 Sanofi India Ltd.
5,503.05(1.37)
3325
 Pfizer Ltd.
3,247.25(-0.78)
3370
 Dr. Reddy`s Laboratories Ltd.
2,535.00(0.92)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.-104.20-179.75-213.75
NIFTY(S&P CNX)-128.30442.201,066.60
BSE SENSEX-248.351,626.033,785.00
BSE 500-270.00336.75919.20

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Exe. & Ind. Director
Brian W Tempest
Non Exe. & Ind. Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Fintech Pvt. Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda Serilingampally Mandal